MARY ANN GRAY

CIK 1261974 · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.95M

Companies

15

Total Filings

94

Lifetime Open-Market Net

-$829.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KROS Director 12,392 $10.07 $124.8K $0 7 2026-06-05
RAPT Therapeutics, Inc. (RAPT) Delisted Director 4,956 $58.01 $287.5K $0 14 2026-02-02
CMPX Director $2.04 $0 5 2026-01-05
BCAB Director 1,548 $3.53 $5.5K $0 9 2025-06-18
PALI Director $2.02 $0 3 2023-11-24
SRPT Director 12,356 $15.43 $190.7K $0 8 2022-03-08
PALISADE BIO, INC. (SNCA) Delisted Director $9.96 $0 2 2021-04-26
SENOMYX INC (SNMX) Delisted Director 0 $10.0K 10 2018-11-02
JUNIPER PHARMACEUTICALS INC (JNP) Delisted Director 0 $0 4 2018-08-15
SELLAS Life Sciences Group, Inc. (GALE) Delisted Director 1,306 $0 6 2017-10-10
ACAD Director 139,476 $26.01 $3.63M -$847.8K 13 2016-06-09
DYAX CORP (DYAX) Delisted Director 0 $0 5 2016-01-22
TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted Director $0 2 2015-01-30
GTC BIOTHERAPEUTICS INC (GTCB) Delisted Director 1,100 $8.8K 3 2008-06-25
MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Director $0 2 2008-05-22

Recent Filings · Page 2 of 10

94 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-06-03 KROS Grant (A) $0 EDGAR
2024-05-23 RAPT Therapeutics, Inc. (RAPT) Delisted Grant (A) $0 EDGAR
2024-04-01 RAPT Therapeutics, Inc. (RAPT) Delisted Grant (A) $0 EDGAR
2024-02-14 CMPX Grant (A) $0 EDGAR
2024-01-03 BCAB Grant (A) +5,995 $0 EDGAR
2023-11-24 PALI Grant (A) $0 EDGAR
2023-10-03 BCAB Grant (A) +8,676 $0 EDGAR
2023-07-05 BCAB Grant (A) +4,916 $0 EDGAR
2023-06-15 BCAB Grant (A) $0 EDGAR
2023-06-13 PALI Grant (A) $0 EDGAR
Showing 1120 of 94
Page 2 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.